ECOG-ACRIN Cancer Research Group

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

Prudence A. Francis, Meredith M. Regan, Gini F. Fleming et al. · New England Journal of Medicine · 2014 · 727 citations · Full text

Medicine, Gynecology, Oncology +16

Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF^V600E</i> Mutations: Results of the NCI-MATCH Trial Subprotocol H

April K.S. Salama, Shuli Li, Erin Macrae et al. · Journal of Clinical Oncology · 2020 · 296 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)

Keith T. Flaherty, Robert J. Gray, Alice P. Chen et al. · Journal of Clinical Oncology · 2020 · 295 citations · Full text

Medicine, Cancer Biology, Oncology +17

Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial

Savannah C. Partridge, Zheng Zhang, David C. Newitt et al. · Radiology · 2018 · 284 citations

Medicine, Oncology, Radiology +17

The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design

Keith T. Flaherty, Robert J. Gray, Alice P. Chen et al. · JNCI Journal of the National Cancer Institute · 2020 · 228 citations · Full text

Medicine, Molecular Medicine, Oncology +17